loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1997_103___rev_07 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Chongqing DaXin Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CHONGQING DAXIN PHARMACEUTICAL CO., LTD. Chongqing CN (1)

    filter

    01 Tobramycin (1)

    filter

    01 China (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CHONGQING DAXIN PHARMACEUTICAL CO.,...

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Tobramycin

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 1997-103 - Rev 07
    Withdrawn by Holder
    Chemical
    2018-09-18
    2021-08-26
    645
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-103 - Rev 07 of Chongqing Daxin Pharmaceutical Co., Ltd. Chongqing Cn

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-103 - Rev 07 of Chongqing Daxin Pharmaceutical Co., Ltd. Chongqing Cn 1

    20

    Chongqing Daxin Pharmaceutical Co., Ltd. Chongqing Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Tobramycin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1997-103 - Rev 07

    This Chemical Type CEP, issued on September 18, 2018, remains in force until August 26, 2021, ensuring its reliability within the pharmaceutical industry.

    Substance Number 645 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY